Clinical Trial on Abdominal Neoplasm - Clinical Trials Registry

Study Overview

Status

Recruiting

Conditions

Abdominal Neoplasm

Detailed Description

Secondary objective: To establish a grading model of abdominal tumors based on clinical indicators Exploratory Objective: To include CT scans in large-scale non-tumor populations for validation and to improve model accuracy Certainty

Study Type

Observational

Enrollment (Estimated)

100000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: Xiangdong Cheng
Phone Number: 0086-571-881280
Email: Chengxd516@126.com

Study Contact Backup

Name: Can Hu
Phone Number: 13968032995
Email: chengxd@zjcc.org.cn

Study Locations

China
- Zhejiang
  - Hangzhou, Zhejiang, China, 310000
    - Recruiting
    - Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)
    - Contact:
      
      Xiangdong Cheng, PhD.
      
      Phone Number: +0086-0571-88128041
      
      Email: chengxd516@126.com
  - Hangzhou, Zhejiang, China, 310022
    - Recruiting
    - Zhejiang Cancer Hospital；Cancer hospital of the university of chinese academy of sciences
    - Contact:
      
      Pengfei Yu, MD，PhD
      
      Phone Number: +86-571-88128031
      
      Email: ypfzmu@163.com
    - Principal Investigator:
      
      Xiangdong Cheng, MD，PhD
    - Sub-Investigator:
      
      Yu Pengfei, MD，PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

Adult
Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Patients with abdominal tumors or Non-tumor population

Description

Inclusion Criteria:

Patients with abdominal tumors:
all patients were pathologically diagnosed with abdominal tumors;
The clinical case data of all patients were complete, and complete follow-up was obtained, with clear information on medical visits, operation time and survival status within 2 years. If the cause of death is unknown, it will be recorded as censored data;
All patients had no history of active abdominal bleeding, no serious infection or other abdominal diseases that affected the observation of CT imaging within 3 months before surgery.
Non-tumor population:
all patients have complete clinical case data, complete abdominal CT, no history of malignant tumors, no serious infections or other abdominal diseases that affect the diagnosis and observation of CT imaging.

Exclusion Criteria:

Cases in which contrast-enhanced or noncontrast CT images show unclear lesions, with significant noise and artifacts;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Whether or not there is a diagnosis of abdominal tumor questionnaire Time Frame: first visited at baseline	Whether or not there is a diagnosis of abdominal tumor	first visited at baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Xiangdong Cheng

Investigators

Principal Investigator: Xiangdong Cheng, Zhejiang Cancer Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2024

Primary Completion (Estimated)

December 31, 2029

Study Completion (Estimated)

December 31, 2029

Study Registration Dates

First Submitted

September 1, 2024

First Submitted That Met QC Criteria

September 25, 2024

First Posted (Actual)

September 26, 2024

Study Record Updates

Last Update Posted (Actual)